Drupal.behaviors.print = function(context) {window.print();window.close();}>

Pronota Signs Agreement with Molecuence to Develop Protein Biomarkers for Stroke

February 25, 2011

Pronota Signs Agreement with Molecuence to Develop Protein Biomarkers for Stroke

Pronota will use its proprietary biomarker discovery platform MASStermind and verification platform MASSterclass on the project.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories